References
- Calhoun JH, Manring MM.Adult osteomyelitis. Infect Dis Clin North Amer 2005; 19: 765–786
- Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier sys-tems for the local delivery of antibiotics in bone infections. Drugs 2000; 59: 1223–1232
- Buttaro M, Comba F, Piccaluga F. Vancomycin-supple-mented cancellous bone allografts in hip revision surgery. Clin Orthop Relat Res. 2007; 461: 74–80
- Trampuz A, Zimmerli W. Antimicrobial agents in or-thopaedic surgery: prophylaxis and treatment. Drugs 2006; 66: 1089–105
- Kuti JL, Kiffer CR, Mendes CM, Nicolau DP. Pharmaco-dynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Clin Mi-crobiol Infect 2008; 14: 116–123
- Witso E, Persen L, Benum P, Bergh K. Release of netilmicin and vancomycin from cancellous bone. Acta Orthop Scand 2002; 73: 199–205
- Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impreg-nated human and bovine bone grafts. J Antimicrob Chemother 2000; 46: 423–428
- Witso E, Persen L, Loseth K, Benum P, Bergh K. Cancel-lous bone as an antibiotic carrier. Acta Orthop Scand 2000; 71: 80–84
- Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supple-mented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 2005; 87: 314–319
- Buttaro MA, Morandi A, Rivello HG, Piccaluga F. Histol-ogy of vancomycin-supplemented impacted bone allografts in re-vision total hip arthroplasty. J Bone Joint Surg Br 2005; 87: 1684–1687
- Chen CE, Ko JY, Pan CC. Results of vancomycin-im-pregnated cancellous bone grafting for infected tibial nonunion. Arch Orthop Trauma Surg 2005; 125: 369–375
- Chan YS, Ueng SW, Wang CJ, Lee SS, Chen CY, Shin CH. Antibiotic-impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small in-fected tibial defects: a comparison study. J Trauma 2000; 48: 246–255
- Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, Ghisellini F, Ritter MA. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty 2002; 17: 619–626
- Bogdanovich T, Ednie LM, Shapiro S, Appelbaum PC. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 2005; 49: 4210–4219
- Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients. J Antimicrob Chemother 2006; 58: 470–473